Detalhe da pesquisa
1.
Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs.
Hepatol Res
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539054
2.
Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study.
Jpn J Clin Oncol
; 54(2): 175-181, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899139
3.
Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
J Gastroenterol Hepatol
; 38(9): 1637-1646, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37475200
4.
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
Int J Cancer
; 151(12): 2278-2290, 2022 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054900
5.
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
J Gastroenterol Hepatol
; 36(6): 1685-1693, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326154
6.
Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors.
Oncology
; 98(10): 727-733, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712613
7.
Impact of MAFLD criteria on postoperative recurrence of non-B, non-C HCC.
Eur J Gastroenterol Hepatol
; 36(4): 430-437, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407856
8.
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
Cancers (Basel)
; 16(7)2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38611007
9.
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
Cancer Med
; 13(5): e7025, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477514
10.
Sodium-glucose cotransporter-2 inhibitors improve FibroScan-aspartate aminotransferase scores in patients with nonalcoholic fatty liver disease complicated by type 2 diabetes.
Eur J Gastroenterol Hepatol
; 35(9): 989-996, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395206
11.
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Consideration of the Locations of Target Lesions.
Cancers (Basel)
; 15(3)2023 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765804
12.
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure.
Hepatol Int
; 17(5): 1225-1232, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101102
13.
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.
Cancers (Basel)
; 15(8)2023 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190231
14.
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 15(22)2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001666
15.
Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma.
Commun Med (Lond)
; 3(1): 152, 2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880538
16.
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.
Cancers (Basel)
; 15(17)2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686510
17.
Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 14(20)2022 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291850
18.
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 14(2)2022 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053484
19.
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
J Exp Clin Cancer Res
; 40(1): 215, 2021 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174931
20.
Successful multimodality treatment for advanced hepatocellular carcinoma with tumor thrombosis of the main portal trunk: a case study.
Clin J Gastroenterol
; 14(5): 1517-1524, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34291386